Abbott Laboratories Announces $20 Billion Senior Notes Offering

Wachtell, Lipton, Rosen & Katz has advised Abbott Laboratories. Abbott Laboratories has priced a registered public offering of $20 billion in senior notes. The proceeds from…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here